BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1720
-0.0080 (-4.44%)
Mar 5, 2026, 1:40 PM EST

BioLargo Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.78-2.4-3.5-4.47-7.08
Depreciation & Amortization
0.410.260.270.050.02
Other Amortization
0.2-00.020.12
Asset Writedown & Restructuring Costs
--0.390.20.34
Loss (Gain) From Sale of Investments
0.010.010.010.020.02
Stock-Based Compensation
3.612.482.512.362.24
Provision & Write-off of Bad Debts
3.890.010.09--
Other Operating Activities
-3.63-2.02-1.22-0.680.16
Change in Accounts Receivable
-1.81-0.57-1.63-0.55-0.03
Change in Inventory
0.02-0.18-0.09-0.040.04
Change in Accounts Payable
0.64-0.40.470.390.18
Change in Unearned Revenue
0.28-0.30.29-0.070.04
Change in Other Net Operating Assets
-0.13-0.090.050.020.02
Operating Cash Flow
-8.3-3.21-2.37-2.76-3.94
Capital Expenditures
-0.05-1.24-0.48-0.27-0.02
Sale (Purchase) of Intangibles
-----0.01
Other Investing Activities
0.48-0.08---
Investing Cash Flow
0.44-1.32-0.48-0.27-0.03
Long-Term Debt Issued
1.290.860.070.1-
Total Debt Issued
1.290.860.070.1-
Short-Term Debt Repaid
-----0.83
Long-Term Debt Repaid
--0.01-0.03-0.03-0.04
Total Debt Repaid
--0.01-0.03-0.03-0.87
Net Debt Issued (Repaid)
1.290.850.040.07-0.87
Issuance of Common Stock
4.791.583.013.665.05
Other Financing Activities
-2.011.610.230.05
Financing Cash Flow
8.224.444.663.964.23
Foreign Exchange Rate Adjustments
-0.020.09-0.13-0.03-0.01
Net Cash Flow
0.340.011.690.890.25
Free Cash Flow
-8.34-4.44-2.84-3.03-3.96
Free Cash Flow Margin
-107.44%-24.98%-23.25%-51.55%-156.38%
Free Cash Flow Per Share
-0.03-0.01-0.01-0.01-0.02
Cash Interest Paid
0.340.030.060.040.1
Cash Income Tax Paid
---00
Levered Free Cash Flow
-5.33-2.34-0.96-1.13-2
Unlevered Free Cash Flow
-5.19-2.32-0.91-1.11-1.98
Change in Working Capital
-1-1.54-0.92-0.250.25
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.